AOSSM Update: "The Boom of Peptides in Sports Medicine — Do We Know Anything More?"
The American Orthopaedic Society for Sports Medicine published an April 2026 update revisiting the evidence base for peptide therapy in sports medicine. The piece reflects increasing surgeon-side concerns about patients self-administering peptides for recovery from injuries and surgeries, with growing pressure from clinics offering BPC-157 and TB-500 injections. AOSSM's stance remains that current evidence is insufficient to recommend therapeutic peptide use — but the educational push acknowledges the rising clinical reality post-FDA reclassification.